Trade Mark Journal No.2025/033 15 August 2025

WO0000001854618 (5)

Office of origin: United States of America

Date of International Registration:11 March 2025
Date of designation in the UK: 11 March 2025
Image for mark 1854618 AYMROXA

International priority date claimed: 12 September 2024 (United States of America) (98747397)
Class 5
Pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the gastrointestinal disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic dermatitis, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of asthma and other breathing disorders.

Amgen Inc.

Representative: Elsa D. Lemoine Amgen Inc., One Amgen Center Drive,, Trademark Operations MS-28-5A, Thousand Oaks CA 91320-1799, UNITED STATES OF AMERICA